Comparison of scan findings to evaluate ovulation rate in patients undergoing ovulation induction treatment with Letrozole and Clomiphene citrate.
Not Applicable
- Conditions
- Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2021/02/031447
- Lead Sponsor
- Kasturba Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Women undergoing Ovulation induction with Clomiphene citrate or Letrozole
Exclusion Criteria
1. Women undergoing any other form of infertility treatment.
2. Other causes of infertility will be excluded by documentation of a normal uterine cavity, atleast one patent fallopian tube and current partner having a normal semen analysis report
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method effect of clomiphene citrate and letrozole on perifollicular and endometrial vascularityTimepoint: 12 months
- Secondary Outcome Measures
Name Time Method Ovulation rate and pregnancy rate in patients treated with clomiphene citrate and letrozoleTimepoint: 12 months